High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.
Leonce Nshuti, MSc
Advertisement
Articles by Leonce Nshuti, MSc
Advertisement
Latest Updated Articles
- Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs
Published: July 15th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Boosting RSV Vaccination in Older Adults Could Save Thousands
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5
